AMGEN INC. - Daily - Technical analysis published on 11/19/2019 (GMT)
- 383
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Strongly bullish
Technical indicators
72%
0%
28%
My opinion
Bullish above 208.89 USD
My targets
221.31 USD (+0.29%)
My analysis
AMGEN INC. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 208.89 USD. The next resistance located at 221.31 USD is the next bullish objective to be reached. A bullish break in this resistance would boost the bullish momentum. With the current pattern, you will need to monitor for possible bullish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bullish trend. Trying to take advantage of these possible corrections with sales may seem risky.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
FORCE
0
10
8.4
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
AMGEN INC. rating 220.67 USD. The price is lower by -0.09% since the last closing and was traded between 219.21 USD and 221.59 USD over the period. The price is currently at +0.67% from its lowest and -0.42% from its highest.219.21
221.59
220.67
The Central Gaps scanner detects a bullish gap which is a sign that buyers have taken the lead in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of AMGEN INC. in Daily shows a strongly overall bullish trend. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 13 technical indicators on 18 studied are currently positioned bullish. But beware of excesses. The Central Indicators scanner currently detects this:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
The analysis of the price chart with Central Patterns scanners does not return any result.
Central Candlesticks, the scanner specialised in Japanese candlesticks, detects a bullish signal that could support the hypothesis of a small rebound in the very short term:
White morning star
Type : Bullish
Timeframe : Daily
ProTrendLines
S3
S2
S1
R1
Price
| S3 | S2 | S1 | Price | R1 | |
|---|---|---|---|---|---|
| ProTrendLines | 189.14 | 197.76 | 208.89 | 220.67 | 221.31 |
| Change (%) | -14.29% | -10.38% | -5.34% | - | +0.29% |
| Change | -31.53 | -22.91 | -11.78 | - | +0.64 |
| Level | Intermediate | Minor | Major | - | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 214.68 | 215.95 | 218.40 | 219.67 | 222.12 | 223.39 | 225.84 |
| Camarilla | 219.84 | 220.18 | 220.52 | 220.86 | 221.20 | 221.54 | 221.88 |
| Woodie | 215.28 | 216.25 | 219.00 | 219.97 | 222.72 | 223.69 | 226.44 |
| Fibonacci | 215.95 | 217.37 | 218.25 | 219.67 | 221.09 | 221.97 | 223.39 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 202.81 | 208.18 | 214.52 | 219.89 | 226.23 | 231.60 | 237.94 |
| Camarilla | 217.64 | 218.71 | 219.79 | 220.86 | 221.93 | 223.01 | 224.08 |
| Woodie | 203.30 | 208.42 | 215.01 | 220.13 | 226.72 | 231.84 | 238.43 |
| Fibonacci | 208.18 | 212.65 | 215.42 | 219.89 | 224.36 | 227.13 | 231.60 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 171.91 | 180.34 | 196.80 | 205.23 | 221.69 | 230.12 | 246.58 |
| Camarilla | 206.41 | 208.69 | 210.97 | 213.25 | 215.53 | 217.81 | 220.10 |
| Woodie | 175.92 | 182.35 | 200.81 | 207.24 | 225.70 | 232.13 | 250.59 |
| Fibonacci | 180.34 | 189.85 | 195.73 | 205.23 | 214.74 | 220.62 | 230.12 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 69.66 | |
| MACD (12,26,9): | 5.0800 | |
| Directional Movement: | 14.87 | |
| AROON (14): | 64.29 | |
| DEMA (21): | 221.24 | |
| Parabolic SAR (0,02-0,02-0,2): | 224.80 | |
| Elder Ray (13): | 3.08 | |
| Super Trend (3,10): | 210.12 | |
| Zig ZAG (10): | 220.67 | |
| VORTEX (21): | 1.1900 | |
| Stochastique (14,3,5): | 75.82 | |
| TEMA (21): | 223.13 | |
| Williams %R (14): | -21.75 | |
| Chande Momentum Oscillator (20): | 7.42 | |
| Repulse (5,40,3): | 1.6800 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.3500 | |
| Courbe Coppock: | 12.50 |
| MA7: | 220.40 | |
| MA20: | 213.85 | |
| MA50: | 203.84 | |
| MA100: | 197.26 | |
| MAexp7: | 219.55 | |
| MAexp20: | 214.62 | |
| MAexp50: | 206.98 | |
| MAexp100: | 200.11 | |
| Price / MA7: | +0.12% | |
| Price / MA20: | +3.19% | |
| Price / MA50: | +8.26% | |
| Price / MA100: | +11.87% | |
| Price / MAexp7: | +0.51% | |
| Price / MAexp20: | +2.82% | |
| Price / MAexp50: | +6.61% | |
| Price / MAexp100: | +10.27% |
News
Don"t forget to follow the news on AMGEN INC.. At the time of publication of this analysis, the latest news was as follows:
- New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function
- Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors
- The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature
- Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation
- David Meline, Amgen's Chief Financial Officer, To Retire
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis AMGEN INC. - Daily